Contribution of antepartum and intrapartum hemorrhage to the burden of maternal near miss and death in a national surveillance study

To evaluate the occurrence of severe obstetric complications associated with antepartum and intrapartum hemorrhage among women from the Brazilian Network for Surveillance of Severe Maternal Morbidity.

[1]  F. Mercier,et al.  Major obstetric hemorrhage. , 2016, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[2]  K. Huybrechts,et al.  Patterns of Second-Line Uterotonic Use in a Large Sample of Hospitalizations for Childbirth in the United States: 2007-2011 , 2015 .

[3]  K. Huybrechts,et al.  Patterns of Second-Line Uterotonic Use in a Large Sample of Hospitalizations for Childbirth in the United States: 2007–2011 , 2014, Anesthesia and analgesia.

[4]  J. Kingdom,et al.  Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial , 2014, The Lancet.

[5]  D. Schlembach,et al.  New approaches to obstetric hemorrhage: the postpartum hemorrhage consensus algorithm , 2014, Current opinion in anaesthesiology.

[6]  N. Sananès,et al.  [Abruptio placentae. Diagnosis, management and maternal-fetal prognosis: a retrospective study of 100 cases]. , 2014, Gynecologie, obstetrique & fertilite.

[7]  H. Minakami,et al.  Prospective risk of abruptio placentae , 2014, The journal of obstetrics and gynaecology research.

[8]  L. Green,et al.  How we manage the haematological aspects of major obstetric haemorrhage , 2014, British journal of haematology.

[9]  J. Isbister,et al.  Blood Transfusion During Pregnancy, Birth, and the Postnatal Period , 2014, Obstetrics and gynecology.

[10]  R. Favre,et al.  [Abruptio placentae. Diagnosis, management and maternal-fetal prognosis: a retrospective study of 100 cases]. , 2014, Gynecologie, obstetrique & fertilite.

[11]  M. Knight,et al.  Authors' response to: Multiple repeat caesarean section in the UK: incidence and consequences to mother and child. A national, prospective cohort study , 2013, BJOG : an international journal of obstetrics and gynaecology.

[12]  J. Rahman,et al.  Multiple repeat cesarean sections: operative difficulties, maternal complications and outcome. , 2013, The Journal of reproductive medicine.

[13]  G. Lawson,et al.  Reflections on the maternal mortality millennium goal. , 2013, Birth.

[14]  R. Mori,et al.  Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional study , 2013, The Lancet.

[15]  M. Gissler,et al.  Decreasing perinatal mortality in placental abruption , 2013, Acta obstetricia et gynecologica Scandinavica.

[16]  M. Dhanjal,et al.  Multiple repeat caesarean section in the UK: incidence and consequences to mother and child. A national, prospective, cohort study , 2013, BJOG : an international journal of obstetrics and gynaecology.

[17]  P. Brocklehurst,et al.  Incidence and Risk Factors for Placenta Accreta/Increta/Percreta in the UK: A National Case-Control Study , 2012, PloS one.

[18]  Yu-Chun Wang,et al.  Trauma during Pregnancy: A Population-based Analysis of Maternal Outcome , 2012, World Journal of Surgery.

[19]  L. Say,et al.  The WHO Maternal Near-Miss Approach and the Maternal Severity Index Model (MSI): Tools for Assessing the Management of Severe Maternal Morbidity , 2012, PloS one.

[20]  W. Tam,et al.  The risk of preterm delivery prior to 34 weeks in women presenting with antepartum haemorrhage of unknown origin , 2012, The Australian & New Zealand journal of obstetrics & gynaecology.

[21]  Y. Chong,et al.  Massive obstetric haemorrhage with disseminated intravascular coagulopathy. , 2012, Best practice & research. Clinical obstetrics & gynaecology.

[22]  R. Fu,et al.  Impact of multiple cesarean deliveries on maternal morbidity: a systematic review. , 2011, American journal of obstetrics and gynecology.

[23]  L. Say,et al.  Pre-validation of the WHO organ dysfunction based criteria for identification of maternal near miss , 2011, Reproductive health.

[24]  L. Say,et al.  From planning to practice: building the national network for the surveillance of severe maternal morbidity , 2011, BMC public health.

[25]  A. Tesnière,et al.  Hémorragie du post-partum : actualités dans la prise en charge transfusionnelle , 2011 .

[26]  M. Tikkanen.  Placental abruption: epidemiology, risk factors and consequences , 2011, Acta obstetricia et gynecologica Scandinavica.

[27]  A. Tesnière,et al.  [Transfusion for post-partum haemorrhage: what's new in 2011?]. , 2011, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[28]  L. Tsen,et al.  Oxytocin protocols during cesarean delivery: time to acknowledge the risk/benefit ratio? , 2010, International journal of obstetric anesthesia.

[29]  P. Cignini,et al.  Antepartum Haemorrhage , 2010 .

[30]  L. Say,et al.  WHO maternal death and near-miss classifications. , 2009, Bulletin of the World Health Organization.

[31]  L. Say,et al.  Brazilian network for the surveillance of maternal potentially life threatening morbidity and maternal near-miss and a multidimensional evaluation of their long term consequences , 2009, Reproductive health.

[32]  L. Say,et al.  Maternal near miss--towards a standard tool for monitoring quality of maternal health care. , 2009, Best practice & research. Clinical obstetrics & gynaecology.

[33]  J. Kingdom,et al.  Oxytocin–ergometrine co‐administration does not reduce blood loss at caesarean delivery for labour arrest * , 2008, BJOG : an international journal of obstetrics and gynaecology.

[34]  Pedagógia,et al.  Cross Sectional Study , 2019 .

[35]  T. Baskett.  Intrapartum hemorrhage. , 1990, Canadian family physician Medecin de famille canadien.